This handout is for brugada syndrome (chronic ambulatory — scd risk stratification). Your care team identified this based on: type 1 brugada ecg (coved st ≥2 mm v1–v2), spontaneous or provoked.
Other reasons your team may use this plan: unexplained syncope (often nocturnal / at rest); aborted scd / family history of scd or brugada; arrhythmia/syncope during febrile illness.
Take these medications exactly as prescribed. Do not stop or change a dose without talking to your provider.
| Medication | Starting dose | How | When | What it does |
|---|---|---|---|---|
| acetaminophen | 650–1000 mg | PO | q6h PRN fever | Aggressive prompt antipyresis — fever unmasks/triggers Brugada VF; patient-held fever action plan (2022 ESC VA) |
| avoid brugadadrugs.org agents (class IC/IA Na-blockers, select psychotropics, cocaine, excess alcohol) | — | — | — | Na-channel-blocking and other listed drugs precipitate type 1 pattern + VF — lifelong avoidance (brugadadrugs.org; 2013 consensus) |
Plan: Brugada syndrome SCD-protection (2013 HRS/EHRA/APHRS; 2017 AHA/ACC/HRS VA; 2022 ESC VA)
Contact your care team if any of the following happen:
Call 911 or go to the nearest emergency room right away if you have:
First-degree family cascade screening; lifelong drug-avoidance + fever education
Guideline: 2013 HRS/EHRA/APHRS Inherited Arrhythmia Expert Consensus + 2017 AHA/ACC/HRS VA Guideline + 2022 ESC Ventricular Arrhythmia Guideline